We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$7.27B
AUM Growth
+$522M
Cap. Flow
-$742M
Cap. Flow %
-10.21%
Top 10 Hldgs %
4.99%
Holding
2,828
New
364
Increased
958
Reduced
1,209
Closed
291

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$40.1M
2
LMT icon
Lockheed Martin
LMT
+$35.3M
3
ETR icon
Entergy
ETR
+$33.8M
4
CNC icon
Centene
CNC
+$29.8M
5
FIS icon
Fidelity National Information Services
FIS
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 19.45%
2 Consumer Discretionary 14.31%
3 Healthcare 13.04%
4 Industrials 12.87%
5 Financials 12.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLMD icon
2501
Relmada Therapeutics
RLMD
$527M
$20K ﹤0.01%
624
-314
-33% -$10.8K
UEC icon
2502
Uranium Energy
UEC
$5.57B
$20K ﹤0.01%
+11,309
New +$13.4K
CONE
2503
DELISTED
CyrusOne Inc Common Stock
CONE
$20K ﹤0.01%
276
-38,745
-99% -$2.81M
GSM icon
2504
FerroAtlántica
GSM
$839M
$19K ﹤0.01%
+11,407
New +$12K
CNCE
2505
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$19K ﹤0.01%
1,501
-1,316
-47% -$15K
CLVS
2506
DELISTED
Clovis Oncology, Inc.
CLVS
$19K ﹤0.01%
3,913
-21,115
-84% -$107K
TXMD icon
2507
TherapeuticsMD
TXMD
$24M
$18K ﹤0.01%
+301
New +$20.6K
CRNX icon
2508
Crinetics Pharmaceuticals
CRNX
$8.92B
$16K ﹤0.01%
+1,168
New +$16.3K
KODK icon
2509
Kodak
KODK
$983M
$16K ﹤0.01%
2,000
GLNG icon
2510
Golar LNG
GLNG
$5.13B
$14K ﹤0.01%
1,459
-28,187
-95% -$245K
KROS icon
2511
Keros Therapeutics
KROS
$221M
$14K ﹤0.01%
200
-707
-78% -$44.6K
ARGO
2512
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$14K ﹤0.01%
+320
New +$12.8K
GIII icon
2513
G-III Apparel Group
GIII
$1.5B
$13K ﹤0.01%
550
-190,939
-100% -$3.54M
DASH icon
2514
DoorDash
DASH
$93.7B
$11K ﹤0.01%
+76
New +$12.1K
HYFM icon
2515
Hydrofarm Holdings
HYFM
$7.62M
$11K ﹤0.01%
+20
New +$10.5K
BYSI icon
2516
BeyondSpring
BYSI
$35.8M
$10K ﹤0.01%
+785
New +$10.3K
AER icon
2517
AerCap
AER
$23.8B
$9K ﹤0.01%
200
-194,132
-100% -$6.78M
GAN
2518
DELISTED
GAN Ltd
GAN
$9K ﹤0.01%
+465
New +$7.79K
GERN icon
2519
Geron
GERN
$949M
$8K ﹤0.01%
4,921
-14,114
-74% -$25.7K
NGNE icon
2520
Neurogene
NGNE
$712M
$8K ﹤0.01%
+29
New +$7.09K
SNN icon
2521
Smith & Nephew
SNN
$12.6B
$8K ﹤0.01%
200
-15,460
-99% -$612K
FROG icon
2522
JFrog
FROG
$10.8B
$6K ﹤0.01%
+100
New +$6.97K
FULC icon
2523
Fulcrum Therapeutics
FULC
$297M
$6K ﹤0.01%
+545
New +$6.16K
IVA
2524
Inventiva
IVA
$1.13B
$6K ﹤0.01%
420
MP icon
2525
MP Materials
MP
$9.1B
$6K ﹤0.01%
185
-708
-79% -$13.7K

Similar funds

Cubist Systematic Strategies's Q4 2020 Portfolio in Review

As of Q4 2020, Cubist Systematic Strategies held 2,828 positions worth $7.27B, up 7.7% from $6.75B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Cubist Systematic Strategies withdrew a net $742M in Q4 2020, closing 291 positions and reducing 1,209 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $31.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Cubist Systematic Strategies opened a new position in Consolidated Edison worth $15.8M.

  • Cubist Systematic Strategies's largest Q4 2020 buy was Consolidated Edison: 218,137 shares worth $15.8M.
  • Cubist Systematic Strategies added most to Danaher in Q4 2020, an estimated $40.1M increase.
  • Cubist Systematic Strategies's biggest Q4 2020 reduction was Hartford Financial Services, cutting an estimated $32.7M.
  • Cubist Systematic Strategies fully exited State Street SPDR S&P 500 ETF Trust in Q4 2020, selling an estimated $31.4M.
  • Cubist Systematic Strategies's ten largest holdings make up 5% of its $7.27B portfolio in Q4 2020.
  • Cubist Systematic Strategies opened 364 new positions and closed 291 in Q4 2020.
  • Cubist Systematic Strategies's portfolio value rose 7.7% quarter-over-quarter to $7.27B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.